State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.97B |
| 2 |
Apple
AAPL
|
+$2.88B |
| 3 |
Microsoft
MSFT
|
+$2.36B |
| 4 |
Parker-Hannifin
PH
|
+$2.29B |
| 5 |
Sherwin-Williams
SHW
|
+$2.05B |
Top Sells
| 1 |
Chevron
CVX
|
+$1.37B |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
+$967M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$451M |
| 4 |
Marathon Petroleum
MPC
|
+$244M |
| 5 |
Dow Inc
DOW
|
+$217M |
Sector Composition
| 1 | Technology | 29.35% |
| 2 | Financials | 13.83% |
| 3 | Consumer Discretionary | 10.66% |
| 4 | Healthcare | 10.51% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZBIO
3176
Zenas BioPharma, Inc. Common Stock
ZBIO
$849M
| $1.73M | ﹤0.01% |
+211,506
| New | +$1.73M |
|
3177
Stratus Properties
STRS
$160M
| $1.73M | ﹤0.01% |
83,427
-126
| -0.2% | -$2.62K |
|
3178
Solid Biosciences
SLDB
$413M
| $1.73M | ﹤0.01% |
432,176
-9,364
| -2% | -$37.5K |
|
3179
Adverum Biotechnologies
ADVM
$66.1M
| $1.73M | ﹤0.01% |
369,554
-62
| -0% | -$290 |
|
3180
Lunai Bioworks Inc. Common Stock
RENB
$46.2M
| $1.73M | ﹤0.01% |
2,064,859
+741,027
| +56% | +$619K |
|
3181
NN Inc
NNBR
$117M
| $1.72M | ﹤0.01% |
525,708
+11,300
| +2% | +$37K |
|
3182
Brookfield Asset Management
BAM
$91.6B
| $1.69M | ﹤0.01% |
31,269
-2,149
| -6% | -$116K |
|
3183
Ares Capital
ARCC
$15.8B
| $1.68M | ﹤0.01% |
76,823
| – | – |
|
3184
Hamilton Beach Brands
HBB
$197M
| $1.68M | ﹤0.01% |
99,851
+1,509
| +2% | +$25.4K |
|
|
HUYA
3185
Huya Inc
HUYA
$758M
| $1.68M | ﹤0.01% |
546,078
-84,508
| -13% | -$259K |
|
3186
Marine Products Corp
MPX
$323M
| $1.67M | ﹤0.01% |
182,469
+3,511
| +2% | +$32.2K |
|
|
RGLS
3187
DELISTED
Regulus Therapeutics
RGLS
| $1.67M | ﹤0.01% |
1,056,411
+55,413
| +6% | +$87.6K |
|
3188
Tilly's
TLYS
$61.6M
| $1.66M | ﹤0.01% |
391,682
-8,129
| -2% | -$34.5K |
|
|
ARTV
3189
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$64.7M
| $1.66M | ﹤0.01% |
164,783
+78,224
| +90% | +$788K |
|
3190
Neuropace
NPCE
$330M
| $1.66M | ﹤0.01% |
148,303
-7,187
| -5% | -$80.4K |
|
3191
Atossa Therapeutics
ATOS
$106M
| $1.66M | ﹤0.01% |
1,755,369
+23,148
| +1% | +$21.9K |
|
|
TWFG
3192
TWFG, Inc. Common Stock
TWFG
$367M
| $1.66M | ﹤0.01% |
+53,765
| New | +$1.66M |
|
|
BLUE
3193
DELISTED
bluebird bio
BLUE
| $1.65M | ﹤0.01% |
197,921
+5,825
| +3% | +$48.6K |
|
3194
RELX
RELX
$84.4B
| $1.65M | ﹤0.01% |
36,340
-690
| -2% | -$31.3K |
|
3195
Geospace Technologies
GEOS
$213M
| $1.64M | ﹤0.01% |
163,397
-4,100
| -2% | -$41.1K |
|
3196
Escalade
ESCA
$173M
| $1.63M | ﹤0.01% |
113,856
-500
| -0.4% | -$7.14K |
|
3197
Commercial Vehicle Group
CVGI
$71.7M
| $1.61M | ﹤0.01% |
647,845
+2,965
| +0.5% | +$7.35K |
|
3198
Paysign
PAYS
$287M
| $1.6M | ﹤0.01% |
528,237
-1,800
| -0.3% | -$5.44K |
|
3199
Tenaya Therapeutics
TNYA
$215M
| $1.58M | ﹤0.01% |
1,103,092
+44,194
| +4% | +$63.2K |
|
3200
Harvard Bioscience
HBIO
$20M
| $1.57M | ﹤0.01% |
742,605
+25,218
| +4% | +$53.2K |
|